BioTech Drug Development Patient Experience 
Society for Participatory Medicine
JANUARY 27, 2022
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. However, we are still missing the mark with patient involvement to make durable healthcare change towards a culture of patient centricity.
Digital Health Global
NOVEMBER 30, 2023
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
NOVEMBER 20, 2023
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. They can view historic data and forecast future trends.
Society for Participatory Medicine
JANUARY 11, 2022
As a leader in patient advocacy, I am often asked to speak on the topic of patient centricity and patient advocacy from the biotech/pharma perspective. What do we mean by patient centricity or when we say that patients are at the center of what we do or patients are our guiding star?
Expert insights. Personalized for you.
97 
Let's personalize your content